Linked Life Data

15684318

Source:http://linkedlifedata.com/resource/pubmed/id/15684318

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2005-2-28
pubmed:abstractText
To establish the feasibility and efficacy of capecitabine in combination with weekly irinotecan (CAPIRI) with concurrent pelvic radiotherapy (RT) in patients with locally advanced rectal cancer.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1350-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15684318-Adult, pubmed-meshheading:15684318-Aged, pubmed-meshheading:15684318-Antimetabolites, Antineoplastic, pubmed-meshheading:15684318-Antineoplastic Agents, Phytogenic, pubmed-meshheading:15684318-Camptothecin, pubmed-meshheading:15684318-Deoxycytidine, pubmed-meshheading:15684318-Drug Administration Schedule, pubmed-meshheading:15684318-Drug Therapy, Combination, pubmed-meshheading:15684318-Drug Tolerance, pubmed-meshheading:15684318-Feasibility Studies, pubmed-meshheading:15684318-Female, pubmed-meshheading:15684318-Fluorouracil, pubmed-meshheading:15684318-Humans, pubmed-meshheading:15684318-Male, pubmed-meshheading:15684318-Middle Aged, pubmed-meshheading:15684318-Neoadjuvant Therapy, pubmed-meshheading:15684318-Radiation-Sensitizing Agents, pubmed-meshheading:15684318-Rectal Neoplasms, pubmed-meshheading:15684318-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer.
pubmed:affiliation
Onkologisches Zentrum, III Medizinische Klinik, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Theodor-Kutzer-Ufer, D-68167 Mannheim, Germany. ralf.hofheinz@med3.ma.uni-heidelberg.de
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase I